1. Home
  2. OGEN vs AREB Comparison

OGEN vs AREB Comparison

Compare OGEN & AREB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGEN
  • AREB
  • Stock Information
  • Founded
  • OGEN 1996
  • AREB 2014
  • Country
  • OGEN United States
  • AREB United States
  • Employees
  • OGEN N/A
  • AREB N/A
  • Industry
  • OGEN Biotechnology: Pharmaceutical Preparations
  • AREB Plastic Products
  • Sector
  • OGEN Health Care
  • AREB Industrials
  • Exchange
  • OGEN Nasdaq
  • AREB Nasdaq
  • Market Cap
  • OGEN 4.6M
  • AREB 3.7M
  • IPO Year
  • OGEN N/A
  • AREB N/A
  • Fundamental
  • Price
  • OGEN $0.20
  • AREB $3.85
  • Analyst Decision
  • OGEN
  • AREB
  • Analyst Count
  • OGEN 0
  • AREB 0
  • Target Price
  • OGEN N/A
  • AREB N/A
  • AVG Volume (30 Days)
  • OGEN 376.3K
  • AREB 22.0M
  • Earning Date
  • OGEN 05-14-2025
  • AREB 04-09-2025
  • Dividend Yield
  • OGEN N/A
  • AREB N/A
  • EPS Growth
  • OGEN N/A
  • AREB N/A
  • EPS
  • OGEN N/A
  • AREB N/A
  • Revenue
  • OGEN N/A
  • AREB $11,420,268.00
  • Revenue This Year
  • OGEN N/A
  • AREB N/A
  • Revenue Next Year
  • OGEN N/A
  • AREB N/A
  • P/E Ratio
  • OGEN N/A
  • AREB N/A
  • Revenue Growth
  • OGEN N/A
  • AREB N/A
  • 52 Week Low
  • OGEN $0.16
  • AREB $1.10
  • 52 Week High
  • OGEN $3.43
  • AREB $231.75
  • Technical
  • Relative Strength Index (RSI)
  • OGEN 43.74
  • AREB 43.84
  • Support Level
  • OGEN $0.16
  • AREB $1.80
  • Resistance Level
  • OGEN $0.21
  • AREB $4.79
  • Average True Range (ATR)
  • OGEN 0.01
  • AREB 3.02
  • MACD
  • OGEN 0.00
  • AREB 0.04
  • Stochastic Oscillator
  • OGEN 74.00
  • AREB 14.04

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.

About AREB American Rebel Holdings Inc.

American Rebel Holdings Inc develops self-defense, safe storage, and patriotic products. It designs, manufactures, and markets concealed carry products. It offers products ranging in Backpacks, vault doors, and Others.

Share on Social Networks: